image_alt_text
1

Kang Zhang, M.D., Ph.D.

AIMBE College of Fellows Class of 2016
For outstanding contributions in basic research and clinical applications to advancing genomics, stem cell, tissue engineering, and drug delivery

Blood test may find liver cancer earlier, improve survival

Via San Diego Union Tribune. | October 11, 2017

Liver cancer can be caught at an early stage through a newly developed blood test, improving the odds for survival, according to a study led by University of California San Diego scientists.

The test looks for changed gene activity, caused by a process called methylation, that indicate liver cancer, said Kang Zhang, M.D., the study’s senior author. Methylation turns genes on or off, but doesn’t affect the underlying DNA sequence.

Early detection is important for the best outcome, Zhang said. Moreover, a blood test is simpler to administer than an invasive liver biopsy or imaging.

Long-term survival is more likely when the cancer is still localized to the liver than when it has spread, according to the National Cancer Institute… Continue reading.

...

Kang Zhang, M.D., Ph.D. To be Inducted into Medical and Biological Engineering Elite

Via AIMBE | December 13, 2017

WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Kang Zhang, M.D., Ph.D., Professor of Ophthalmology and Chief of Ophthalmic Genetics, Shiley Eye Institute, University of California, San Diego, to its College of Fellows. Dr. Zhang was nominated, reviewed, and elected by peers and members of the College of Fellows For outstanding contributions in basic research and clinical applications to advancing genomics, stem cell, tissue engineering, and drug delivery.

...